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Cellular internalization of cell-penetrating peptide HIV-1 Tat basic domain (RKKRRQRRR) was studied in Triticale cv AC Alta mesophyll
protoplasts. Fluorescently labeled monomer (Tat) and dimer (Tat2) of Tat basic domain efficiently translocated through the plasma membrane of
mesophyll protoplast and showed distinct nuclear accumulation within 10 min of incubation. Substitution of first arginine residue with alanine in
Tat basic domain (M-Tat) severely reduced cellular uptake of the peptide (3.8 times less than Tat). Tat2 showed greater cellular internalization than
Tat (1.6 times higher). However, characteristics of cellular uptake remained same for Tat and Tat2. Cellular internalization of Tat and Tat2 was
concentration dependent and non-saturable whereas no significant change in cellular uptake was observed even at higher concentrations of M-Tat.
Low temperature (4 °C) remarkably increased cellular internalization of Tat as well as Tat2 but M-Tat showed no enhanced uptake. Viability test
showed that peptide treatment had no cytotoxic effect on protoplasts further indicating involvement of a common mechanism of peptide uptake at
all the temperatures. Endocytic inhibitors nocodazole (10 μM), chloroquine (100 μM) and sodium azide (5 mM) did not show any significant
inhibitory effect on cellular internalization of either Tat or Tat2. These results along with stimulated cellular uptake at low temperature indicate that
Tat peptide is internalized in the plant protoplasts in a non-endocytic and energy-independent manner. Competition experiments showed that non-
labeled peptide did not inhibit or alter nuclear accumulation of fluorescent Tat or Tat2 suggesting active transport to the nucleus was not involved.
Studies in mesophyll protoplasts show that internalization pattern of Tat peptide is apparently similar to that observed in mammalian cell lines.
Crown Copyright © 2006 Published by Elsevier B.V. All rights reserved.Keywords: HIV-1 Tat basic domain; Cellular internalization; Plants; Triticale; Mesophyll protoplast1. Introduction
HIV-coded Tat regulatory nuclear protein is 86 amino acids
long and plays an important role in virus replication by binding
to the viral TAR region to transactivate the viral promoter
[1,2,3]. Frankel and Green independently demonstrated cellular
uptake of the purified full length Tat protein by mammalian cell
types when added to the surrounding media [4,5]. These studies
were the first indication of cell permeation properties of TatAbbreviations: CPW, cell protoplast wash; cv, cultivar; dsRNA, double
stranded RNA; EDTA, ethylenediaminetetracetate; FDA, Fluorescein diacetate;
FITC, fluorescein isothiocyanate; HPLC, high performance liquid chromatog-
raphy; MS, Murashige and Skoog; M-Tat, Mutated Tat; PTD, protein
transduction domain; RT, room temperature; ssDNA, single stranded DNA;
TAR, transactivation responsive region; t-Boc, tert-butyloxycarbonyl
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translocation activity of Tat regulatory protein resides in its
nonapeptide basic domain Tat 49–57, RKKRRQRRR [6–8]. Tat
basic domain is one of the shortest known cell-penetrating
peptide that can independently translocate across plasma
membrane with predominant accumulation in the nucleus
especially in the nucleolar region [6]. The number of arginine
residues is the determinant of the translocation ability of Tat
basic domain. Deletion of an arginine residue or substitution
with an alanine residue results in significant reduction of cell
penetration of Tat basic domain in human cultured cells [9]. Tat
is among the most extensively studied cell-penetrating peptide
for human gene therapy (44% cell-penetrating peptide studies
pertain to Tat) [10]. Tat and its oligomers can traverse plasma
membrane with the cargo complex carrying macromolecules of
much higher mass and size than their own. These cargo macro-
molecular components (proteins, drugs or DNA) cannot surpass.V. All rights reserved.
420 A. Chugh, F. Eudes / Biochimica et Biophysica Acta 1768 (2007) 419–426the entry barrier posed by cell membrane via conventional
transport mechanisms. Versatility of Tat basic domain to interact
with different molecules has made it an attractive tool for
developing novel strategies for cellular delivery, thereby, adding
new dimensions to human therapeutics and diagnostics [11].
Transduction and subcellular localization of various proteins
(such as galactosidase, horse radish peroxidase, GFP) by fusion
with Tat basic domain or linkage by streptavidin/biotin
conjugation has been reported in different mammalian cell
types [10,12–16]. The delivered proteins maintain their
functionality and are biologically active in the cells. Tat can
also mediate delivery of oligonucleotides [17], liposomes [18]
and plasmid [19]. Branched version of Tat (8Tat) and the factors
controlling the efficiency of Tat-mediated plasmid transfer have
been studied [20,21]. Tat oligomers can also effectively
translocate peptide–plasmid complex and exhibit enhanced
gene expression in the presence of standard cationic transfection
agents [22,23]. However, despite wide application of Tat basic
domain in in vitro and in vivo studies in a range of mammalian
cell lines, mechanism of its translocation across the biomem-
branes remains elusive and controversial by large. A number of
reports suggest that cellular internalization of Tat occurs by free
means, it is non-receptor mediated, endocytosis-independent but
concentration-dependent [6,24]. Contradictory reports on in-
volvement of endocytosis and membrane surface receptors such
as heparan sulphate proteoglycans in translocation of Tat-
mediated cellular delivery have appeared [22,23,25–28].
Interestingly, investigations on cellular internalization, cargo
delivery by Tat and other cell-penetrating peptides have been
mainly carried in the mammalian cell lines. In plants, peptide-
mediated cellular delivery is a relatively nascent field. Cellular
internalization of cell-penetrating peptides such as pVEC,
transportan and penetratin has been recently reported in tobacco
protoplasts derived from suspension cell culture [29]. Cellular
uptake of arginine rich intercellular domain (AID) fusion
proteins has been shown in onion epidermal and root tip cells,
and tomato root cells [30]. Synthetic cationic homoarginine
(R12) oligopeptide has been reported to deliver dsRNA into
tobacco cells to induce post-transcriptional gene silencing [31].
However, cellular uptake of Tat basic transduction domain has
not been characterized in plant cells. Keeping in view, the
tremendous potential of cell-penetrating peptides in plant
biotechnology, the present study has been undertaken to
investigate cellular internalization of monomer (Tat) and
dimer (Tat2) of Tat basic domain in triticale mesophyll
protoplasts. Triticale is a man made cereal (wheat× rye) with
commercial and biotechnological value. Mesophyll protoplasts
are a convenient system to investigate as they can be isolated in
abundance with relative ease from leaves than protoplasts from
any other plant tissue. Fluorescence microscopy and fluorimet-
ric analysis were used to investigate translocation of fluores-
cently labeled Tat and Tat2 across the plasma membrane of
protoplasts. M-Tat served as negative control along with FITC-
dextran sulphate. Influence of concentration, temperature,
endocytic inhibitor(s) along with competition experiments
with non-labeled peptide were undertaken to characterize
cellular uptake of Tat peptides in mesophyll protoplasts.2. Materials and methods
2.1. Mesophyll protoplast isolation and purification
Protoplast isolation and purification was carried out under aseptic
conditions. Embryonal halves of the seeds of Triticale cv AC Alta were surface
sterilized with 4% hypochlorite and inoculated on basal MS medium, pH 5.82
[32]. Peeled leaves from six-day-old seedlings were incubated in enzyme
solution [2% cellulase and 2% macerozyme (Yakult Honsha Co Ltd., Japan)
CPW solution, pH 5.6] for 4 h in dark, 25 °C. Protoplasts were isolated by
centrifugation at 100×g, 3 min, RT (Eppendorf centrifuge 5810R, USA) washed
twice with CPW solution and purified by layering on 21% sucrose in CPW
solution. A band of protoplasts formed at the interphase was carefully removed
and suspended in CPW solution. After two washings with CPW solution,
protoplast density was adjusted to 106 protoplasts/ml.
2.2. Peptides synthesis and fluorophore labeling
Tat (RKKRRQRRR), Tat2 (RKKRRQRRRRKKRRQRRR) and M-Tat
(AKKRRQRRR) were custom synthesized at the Alberta Peptide Institute,
University of Alberta, Canada. In brief, peptides were synthesized by solid-phase
synthesis (model 430A, Applied Biosytems, Canada) using t-Boc strategy as
reported by Hodges et al. [33]. For fluorophore labeling, carboxyfluorescein was
added to the N-terminus of protected peptide before cleavage. Peptide cleavage
from the resin was carried out with hydrofluoric acid. The product was purified
on Zorbax 300SB-C8 reverse phase column. Fractions were identified by
analytical HPLC (HP1100) on Discovery C8 column. Pure fractions were pooled
and freeze dried. The purified product was hydrolyzed with HCl and analyzed on
a Beckman 6300 amino acid analyzer using System Gold. Peptide molecular
weight was confirmed usingMALDI-TOF (Voyager DE Pro) mass spectrometry.
2.3. Incubation of protoplasts with fluorescently labeled Tat peptides
Mesophyll protoplasts (500 μl of 106/ml) were incubated with 400 μl
fluoresceinated Tat, Tat2 or M-Tat (5 μM) for 1 h in dark, RT, followed by
washings with CPW solution. Protoplasts were then treated with Trypsin-EDTA
(0.25%, Sigma-Aldrich):CPW solution (1:4) for 5 min followed by washings
and final suspension in 500 μl CPW solution. The parameters remained constant
for all the experiments unless otherwise mentioned.
2.4. Fluorescence microscopy
Protoplasts were observed under the fluorescence microscope (Axioskop 2
Mot Plus, Zeiss Inc, Germany) for cellular uptake and nuclear localization of
fluoresceinated Tat and Tat2 (Ex 490 nm /Em 520 nm). The percentage of
protoplasts showing fluorescence was calculated using hemocytometer.
2.5. Fluorimetric analysis
The amount of fluorescence internalized by the protoplasts was detected
using fluorimeter (Biorad, Versafluor, USA; Ex 490 nm /Em 520 nm).
Protoplasts were lysed with 200 μl of 1% TritonX-100 (prepared in CPW
solution) for 20 min, 4 °C. Besides treatment with M-Tat, set of negative
controls comprised of protoplasts without any treatment and treated with FITC-
dextran sulphate (Sigma Aldrich, 4000 kDa). Fluorimetric data presented is
relative fluorescence uptake detected for each treatment.
2.6. Effect of different factors and inhibitors on cellular internalization
of Tat and Tat2
Concentration—Protoplasts were incubated with varying concentrations of
fluoresceinated Tat, Tat2 or M-Tat (0–30 μM). For each concentration 400 μl of
the peptide was added with all the other parameters remaining the same as
described in Section 2.3.
Temperature—Protoplasts were incubated with fluoresceinated Tat, Tat2 or
M-Tat at different temperatures (4 °C–37 °C) for 1 h in dark. Prior to incubation
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for 20 min.
FDA staining test for protoplast viability—Viability of the protoplasts was
tested after peptide treatment at different temperatures (4 °C–37 °C) using FDA
staining method. A control with no peptide treatment was maintained at every
temperature. Immediately after treatment, protoplasts (100 μl of 106/ml density)
were incubated with 3 μl of 100 ng /ml FDA stain for 5 min in dark, RT. For the
viability test non-labeled Tat or Tat2 were employed to avoid interference by
fluorescein of the labeled peptide with FDA under the fluorescence microscope.
Viable protoplasts, that is fluorescing protoplasts were counted using
hemocytometer.
Endocytic inhibitors—Protoplasts were pre-incubated with endocytic
inhibitors [nocodazole (10 μM), chloroquine (100 μM), sodium azide
(5 mM)] for 30 min, RT, followed by addition of fluoresceinated Tat or Tat2.
2.7. Competition experiments
Competition experiments comprised of two sets: In the first set, the final
concentration of the peptide added was fixed (5 μM). Various ratios of labeled
and non-labeled peptide were employed (5:0, 4:1, 3:2, 2:3, 1:4, 0:5). In another
set, a mixture of fixed concentration of fluoresceinated peptide (5 μM) with 5,
7.5, 10, 15, 20 μM of non-labeled peptide was added to the protoplasts. After
incubation for 1 h, RT, protoplasts were washed with CPW solution followed by
trypsin treatment and observed under fluorescence microscope or used for
fluorimetric analysis.
3. Results
Potential for translocation of fluorescently labeled monomer
and dimer of HIV-1 Tat basic domain was investigated in
triticale mesophyll protoplasts. Influence of various factors such
as peptide concentration, temperature during peptide treatment,
addition of endocytic inhibitors on the cellular uptake of cell-
penetrating peptides was studied. Competition experiments
with non-labeled peptide were also carried to rule out active
nuclear transport of Tat peptides.Fig. 1. Visual fluorescence microscopy showing translocation across cell membrane a
of HIV-1 Tat basic domain in triticale mesophyll protoplasts. The protoplasts were inc
1 h, RT. (A) control; (B) M-Tat; (C) Tat; (D) Tat2. (Nu, Nucleus; Cl, Chloroplast).3.1. Translocation and nuclear accumulation of
fluoresceinated Tat and Tat2 in triticale mesophyll protoplasts
Fluorescently labeled Tat and Tat2 were efficiently translo-
cated across the plasma membrane of mesophyll protoplasts and
showed distinct nuclear accumulation. Protoplasts treated with
M-Tat exhibited negligible fluorescence under the microscope.
Also, fluorescence was not observed in the other two negative
controls; untreated protoplasts and treated with FITC-dextran
sulphate (Fig. 1A–D). The percent of protoplasts that showed
fluorescence upon incubation with fluoresceinated Tat and Tat2
was 20% and 23.5%, respectively (Fig. 2A). Sometimes, in case
of Tat2, fluorescence was also observed in the cytoplasm but not
in a significant number of protoplasts compared to the distinct
nuclear accumulation (data not shown).
Detection of cellular internalization of fluoresceinated Tat
and Tat2 was also carried out using fluorimeter. Tat2 showed 1.6
times higher cellular translocation than Tat where as protoplasts
incubated with M-Tat showed 3.8 and 6.3 times less
fluorescence than Tat and Tat2, respectively. Fluorescence was
detected neither in the protoplasts treated with FITC-dextran
sulphate nor in the untreated protoplasts (Fig. 2B).
3.2. Effect of concentration and temperature on cellular
internalization of Tat peptides in triticale mesophyll protoplasts
Fluorimetric analysis revealed concentration dependent
increase in the cellular internalization of fluoresceinated Tat
and Tat2. The two peptides showed similar pattern of con-
centration curve. Besides, the cellular uptake was non-saturable
as the amount of fluorescence increased with the increase in
concentration (0–30 μM; Fig. 3). Notably, M-Tat did not shownd nuclear accumulation of fluorescently labeled monomer (Tat) and dimer (Tat2)
ubated with 5 μM fluoresceinated cell-penetrating peptides in CPW solution for
Fig. 4. (A) Effect of temperature on cellular internalization of the Tat peptides.
(B) Viability test for protoplasts upon treatment with Tat peptides at different
temperatures.Fig. 2. Comparative cellular uptake of Tat peptides in triticale mesophyll
protoplasts as observed under fluorescence microscope and by fluorimetric
analysis. The protoplasts were incubated with 5 μM fluoresceinated cell-
penetrating peptides in CPW solution for 1 h, RT. (A) (%) Fluorescent
protoplast. (B) Relative fluorescence uptake.
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concentration.
Translocation of both Tat and Tat2 increased remarkably at
low temperature (4 °C) as detected by fluorimetric analysis (1.6
times higher than RT). On the other hand, there was 1.5 times
reduction in fluorescence uptake at higher temperature (37 °C).
However, temperature range of 15 °C–28 °C did not have any
significant influence on translocation of the peptides (Fig. 4A).
Interestingly, at all the temperatures, the protoplasts showed
nuclear accumulation of fluorescently labeled peptides. Low
temperature did not enhance the cellular uptake of M-Tat as
negligible fluorescence uptake was detected in comparison to
Tat and Tat2 (Fig. 4A).Fig. 3. Fluorimetric studies of the effect of concentration on the permeation
potential of fluorescently labeled Tat peptides; Tat, Tat2 and M-Tat in triticale
mesophyll protoplasts.Protoplast viability was unaffected by the peptide treatment
at temperature range 4 °C–24 °C, however, loss of viability was
observed at higher temperature (37 °C) for the control as well as
the treated samples (Fig. 4B).
3.3. Influence of inhibitors on cellular internalization of Tat
peptides in triticale mesophyll protoplasts
Nocodazole (10 μM), chloroquine (100 μM) and sodium
azide (5 mM) are commonly used inhibitors for endocytosis.
Fluorimetric studies showed none of these compounds had
significant inhibitory effect on translocation of either Tat or Tat2
in mesophyll protoplasts (Fig. 5).
3.4. Competition experiments
Two sets of competition assays were performed using
labeled and non-labeled peptides. In the first set, concentration
of the labeled peptide was varied from 0 to 5 μMwith respect toFig. 5. Effect of endocytic inhibitors on permeation of Tat peptides in triticale
mesophyll protoplasts; Nocodazole (10 μM), chloroquine (100 μM), sodium
azide (5 mM).
Fig. 7. Competition experiments suggested free, passive nuclear transport of Tat
peptides. (A) Total peptide concentration was kept constant (5 μM) and the ratio
of labeled and non-labeled peptide was varied. (B) concentration of the labeled
peptide was fixed (5 μM) and concentration of the non-labeled peptide was
increased maximum up to 20 μM.
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for the total peptide added (5 μM). The results revealed that
nuclear accumulation of the fluorescence was dependent on the
concentration of fluoresceinated peptide, irrespective of the
concentration of non-labeled peptide added (Fig. 6). In the
second set, the concentration of labeled peptide was maintained
constant where as concentration of the non-labeled peptide was
increased. Fluorescence microscopy and fluorimetric analysis
showed no change in the nuclear accumulation of fluorescence
(5 μM Tat or Tat2) even in the presence of four times higher
concentration of non-labeled peptide (Figs. 6D, Fig. 7A and B)
further indicating receptor-independent, free, passive nuclear
transport of the Tat peptides.
4. Discussion
Structural and functional studies for HIV-1 Tat basic domain
(also a PTD) have been carried out extensively in mammalian
cell lines, however, there are sporadic reports on cell-
penetrating peptides in general and Tat in particular, in the
plant system.
The present investigation shows efficient translocation and
nuclear accumulation of fluoresceinated monomer and dimer of
Tat basic domain in triticale mesophyll protoplasts. Cellular
internalization of the dimer (Tat2) was higher by 1.6 times than
the Tat monomer. Studies have shown that presence of at least
six arginine residues is required for effective translocation of Tat
and with the increase in the number of arginine residues, the
translocation ability also increases [9,34]. In the present study, itFig. 6. Competition experiment with non-labeled Tat showing free nuclear
transport of Tat peptide. Protoplasts were treated with fluorescently labeled and
non-labeled Tat in different ratios (please see text for details). (A) Control; (B)
non-labeled Tat; (C) total concentration of peptide 5 μM; 3 μM labeled Tat
mixed with 2 μMof non-labeled Tat (3:2), note the weak fluorescence in nucleus
is due to low concentration of the labeled Tat used. (D) 5 μM of labeled Tat
mixed with 20 μM non-labeled peptide (1:4). Similar results were obtained with
Tat2.is possible that higher translocation ability of Tat2 than Tat is
due to higher number of arginine residues. Also, gene transfer
efficiency of Tat dimer in the presence of standard transfection
agent was found higher in human bronchoepithelial cells than
the other oligomers [23]. Multivalency as in case of immuno-
globulins may also enhance the functionality of cationic
peptides by increasing cell penetrability and nuclear accumu-
lation of cargo complexes [35].
The sequence specific effect was most noticeable in mutated
Tat (M-Tat) which served as an excellent negative control.
Substitution of first arginine residue with alanine (M-Tat)
diminished both cell penetration as well as nuclear localization
properties of Tat, further confirming that arginine residue play
an important role in cell penetration ability of Tat peptide.
Tat and Tat2 in the present study were internalized by the
mesophyll protoplasts and showed nuclear accumulation within
10 min of incubation. Histones with much greater size than the
cell-penetrating peptides have been reported to rapidly
translocate and accumulate in the nucleus of petunia protoplasts
[36].
Mechanism of translocation of Tat and cell-penetrating
peptides across plasma membrane in animal cells still remains
unclear [37–40]. Cell-penetrating peptides are speculated to
enter the cell via non-endocytic pathways without any energy
requirements and show increased accumulation in the cells with
increase in their concentration. In the present study also, cellular
internalization of Tat peptides was concentration-dependent and
non-saturable. However, M-Tat showed no significant increase
in cellular uptake even at the highest concentration, again
demonstrating the significance of arginine residue in the cell
penetration ability of the Tat basic domain.
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peptides may require two steps: (1) electrostatic interaction
with membrane phospholipids (2) translocation across the lipid
bilayer by membrane destabilization [41]. Presence of extra
positive charges may change physico-chemical properties of
the membrane phospholipid bilayer resulting in enhanced
permeability [42]. It is possible that excessive peptides enter
the cell by a non-elucidated biological mechanism by interact-
ing with other cell surface components [43]. Penetrating and
conformational investigations reveal that translocation process
of amphipathic cationic peptides may involve formation of
β-barrel pore like structures or an association of helices in
biomembranes [44].
Temperature also influenced the cellular internalization of
Tat and Tat2 in mesophyll protoplasts. Cellular uptake
remarkably increased at 4 °C, as observed in mammalian
cells. Histones have also been reported to show higher cellular
uptake at low temperatures in petunia protoplasts [36].
Stimulated uptake may be due to phase transfer of bio-
membrane phospholipids and stabilization of inverted phos-
pholipids micelles at low temperature [45,46]. We also studied
the effect of peptide treatment on protoplast viability at various
temperatures. Protoplasts like other plant explants are normally
cultured between 20 °C and 28 °C as they are known to loose
viability at higher temperatures such as 37 °C. In the present
study also, the control as well the treated protoplasts maintained
their viability in the temperature range 4 °C–24 °C suggesting
that cellular uptake of peptides in protoplasts occurs via
common non-endocytic mechanism at all the temperatures. The
decrease in the fluorescence uptake at 37 °C was mainly due to
loss of protoplast viability by incubation at high temperature
than due to the peptide treatment. Arginine-rich intracellular
delivery peptides containing fusion proteins also did not show
any cytotoxic effect in onion and tomato cells [30].
In plants, endocytosis is now a well established basic cellular
phenomenon [47–50]. Nocodazole, chloroquine, sodium azide
inhibit the endocytic process in cells in different ways. Pre-
incubation of triticale mesophyll protoplasts with these
endocytic inhibitors did not result in any significant change in
the cellular internalization of Tat and Tat2 peptide. These studies
along with stimulated cellular uptake of peptides at low
temperature suggests that the process is receptor-independent
and may not involve endocytic pathways.
Competition experiments between the labeled and non-
labeled peptides ruled out the possibility of involvement of
active nuclear transport of Tat peptides in mesophyll proto-
plasts. Increase in the concentration of non-labeled peptide did
not cause inhibition of nuclear accumulation of labeled peptide
indicating that the nuclear transport is receptor-independent and
probably passive in nature.
Dual ability of cell-penetrating peptides such as Tat basic
domain to translocate across the plasma membrane with
macromolecular cargo complexes and also act as nuclear
localization signal, has demonstrated their potential to revolu-
tionize the field of bionanomedicine research [51–56]. In
plants, emergence of reports in the last two years on cellular
internalization of cell-penetrating peptides (penetratin, trans-portan and pVEC) and histones [29,36], fusion proteins with
cell-penetrating peptides [30,57] and arginine rich oligopeptide
mediated delivery of dsRNA [31] show that cell-penetrating
peptides indeed could be the ‘peptides of future’ for studying
various fundamental and biotechnological processes in plants.
Cereals such as wheat and triticale are challenging targets for
genetic manipulations through conventional methods of
transformation. Cell-penetrating peptides such as Tat basic
domain can be valuable vectors for alternate, simple and cost-
effective strategies for gene transfer in these commercially
important plant crops.
Also, similar to cell-penetrating peptides, virE2 protein of
Agrobacterium (natural genetic engineer of plants) has nuclear
localization sequence (bipartite) and can mediate nuclear uptake
of ssDNA in plant cells. It will be interesting to carry out
comparative study of the mechanisms of nuclear gene delivery
in plants by virE2 and nuclear targeting cell-penetrating
peptides.
In conclusion, this is the first report of characterization of
cellular internalization of monomer and dimer of Tat basic
domain in plant mesophyll protoplasts. Present investigations
also show significance of sequence of Tat basic domain for
cellular internalization in plants. Cell-penetrating peptides such
as Tat can be used as nanocarriers for delivery of important
macromolecules and hold tremendous potential for developing
an entirely new field in plant sciences in the near future, that
may be aptly called as ‘phyto-nanobiotechnology’!
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